123 related articles for article (PubMed ID: 15569847)
21. Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels.
Raffai RL; Loeb SM; Weisgraber KH
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):436-41. PubMed ID: 15591220
[TBL] [Abstract][Full Text] [Related]
22. Atorvastatin has distinct effects on endothelial markers in different mouse models of atherosclerosis.
Nachtigal P; Jamborova G; Pospisilova N; Pospechova K; Solichova D; Zdansky P; Semecky V
J Pharm Pharm Sci; 2006; 9(2):222-30. PubMed ID: 16959191
[TBL] [Abstract][Full Text] [Related]
23. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
[TBL] [Abstract][Full Text] [Related]
24. Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis.
Zhou X; Robertson AK; Rudling M; Parini P; Hansson GK
Circ Res; 2005 Mar; 96(4):427-34. PubMed ID: 15662027
[TBL] [Abstract][Full Text] [Related]
25. Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice.
Shiraishi Y; Watanabe T; Suguro T; Nagashima M; Kato R; Hongo S; Itabe H; Miyazaki A; Hirano T; Adachi M
J Hypertens; 2008 Oct; 26(10):1955-65. PubMed ID: 18806619
[TBL] [Abstract][Full Text] [Related]
26. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
[TBL] [Abstract][Full Text] [Related]
27. [Sphingolipid probe].
Kozutsumi Y; Aoki T; Yamamoto H
Tanpakushitsu Kakusan Koso; 2002 Mar; 47(4 Suppl):514-8. PubMed ID: 11915351
[No Abstract] [Full Text] [Related]
28. Overexpression of hyaluronan in the tunica media promotes the development of atherosclerosis.
Chai S; Chai Q; Danielsen CC; Hjorth P; Nyengaard JR; Ledet T; Yamaguchi Y; Rasmussen LM; Wogensen L
Circ Res; 2005 Mar; 96(5):583-91. PubMed ID: 15705963
[TBL] [Abstract][Full Text] [Related]
29. Bone morphogenic protein-4 induces hypertension in mice: role of noggin, vascular NADPH oxidases, and impaired vasorelaxation.
Miriyala S; Gongora Nieto MC; Mingone C; Smith D; Dikalov S; Harrison DG; Jo H
Circulation; 2006 Jun; 113(24):2818-25. PubMed ID: 16769910
[TBL] [Abstract][Full Text] [Related]
30. Genetic basis of atherosclerosis: part II: clinical implications.
Lusis AJ; Fogelman AM; Fonarow GC
Circulation; 2004 Oct; 110(14):2066-71. PubMed ID: 15466657
[No Abstract] [Full Text] [Related]
31. The pharmacokinetic behavior of the photosensitizer meso-tetra-hydroxyphenyl-chlorin in mice and men.
Triesscheijn M; Ruevekamp M; Out R; Van Berkel TJ; Schellens J; Baas P; Stewart FA
Cancer Chemother Pharmacol; 2007 Jun; 60(1):113-22. PubMed ID: 17009028
[TBL] [Abstract][Full Text] [Related]
32. Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress.
Cheng C; Tempel D; van Haperen R; van der Baan A; Grosveld F; Daemen MJ; Krams R; de Crom R
Circulation; 2006 Jun; 113(23):2744-53. PubMed ID: 16754802
[TBL] [Abstract][Full Text] [Related]
33. [Current topics for the sphingolipid-mediated signaling pathway].
Sun Y; Tanoue D; Kozutsumi Y
Tanpakushitsu Kakusan Koso; 2001 May; 46(6):706-12. PubMed ID: 11360494
[No Abstract] [Full Text] [Related]
34. Elimination of platelet factor 4 (PF4) from platelets reduces atherosclerosis in C57Bl/6 and apoE-/- mice.
Sachais BS; Turrentine T; Dawicki McKenna JM; Rux AH; Rader D; Kowalska MA
Thromb Haemost; 2007 Nov; 98(5):1108-13. PubMed ID: 18000617
[TBL] [Abstract][Full Text] [Related]
35. [Conditional knockout mouse of sphingolipid biosynthesis].
Osuka S; Takeda J
Tanpakushitsu Kakusan Koso; 2002 Mar; 47(4 Suppl):417-24. PubMed ID: 11915336
[No Abstract] [Full Text] [Related]
36. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis.
Wolfrum C; Poy MN; Stoffel M
Nat Med; 2005 Apr; 11(4):418-22. PubMed ID: 15793583
[TBL] [Abstract][Full Text] [Related]
37. Serum amyloid A and lipoprotein retention in murine models of atherosclerosis.
O'Brien KD; McDonald TO; Kunjathoor V; Eng K; Knopp EA; Lewis K; Lopez R; Kirk EA; Chait A; Wight TN; deBeer FC; LeBoeuf RC
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):785-90. PubMed ID: 15692094
[TBL] [Abstract][Full Text] [Related]
38. Effects of Mycoplasma pneumoniae infection on sphingolipid metabolism in human lung carcinoma A549 cells.
Yu Y; Sun G; Liu G; Wang Y; Shao Z; Chen Z; Yang J
Microb Pathog; 2009 Feb; 46(2):63-72. PubMed ID: 19059331
[TBL] [Abstract][Full Text] [Related]
39. Effect of curcumin on atherosclerosis in apoE/LDLR-double knockout mice.
Olszanecki R; Jawień J; Gajda M; Mateuszuk L; Gebska A; Korabiowska M; Chłopicki S; Korbut R
J Physiol Pharmacol; 2005 Dec; 56(4):627-35. PubMed ID: 16391419
[TBL] [Abstract][Full Text] [Related]
40. Gallic acid antagonizes P-selectin-mediated platelet-leukocyte interactions: implications for the French paradox.
Appeldoorn CC; Bonnefoy A; Lutters BC; Daenens K; van Berkel TJ; Hoylaerts MF; Biessen EA
Circulation; 2005 Jan; 111(1):106-12. PubMed ID: 15630039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
